Td Asset Management Inc reports 33.64% decrease in ownership of 9IP1 / Rocket Pharmaceuticals, Inc.

Rocket Pharmaceuticals, Inc.

DE ˙ DB ˙ US77313F1066

2,44 € 0,00 (0,00%)

2026-06-04
DEL PRIS

Security	DE:9IP1 / Rocket Pharmaceuticals, Inc.
Institution	Td Asset Management Inc
Latest Disclosed Ownership	68,046 shares
Latest Disclosed Value	$ 243,605

On May 11, 2026 - Td Asset Management Inc filed a 13F-HR form disclosing ownership of 68,046 shares of Rocket Pharmaceuticals, Inc. (DE:9IP1) valued at $191,549 USD as of March 31, 2026. The entity filed a previous 13F-HR on February 10, 2026 disclosing 102,538 shares of Rocket Pharmaceuticals, Inc.. This represents a change in shares of -33.64% during the quarter. The current value of the position is $166,032 USD.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel Premium Registration Required .

Disclosed Equity Positions (from 13F/NPORT Filings)

File Date	Effective Date	Form	Security	Class	ID	Reported Shares	ΔShares	ΔShares (%)	Reported Value (x1000)	ΔValue (%)	Alloc (%)
2026-05-11	2026-03-31	13F	ROCKET PHARMACEUTICALS	COM	77313F106	68,046	-34,492	-33.64	244	-32.31	0.0001
2026-02-10	2025-12-31	13F	ROCKET PHARMACEUTICALS	COM	77313F106	102,538	0	0.00	360	7.49	0.0003
2025-11-10	2025-09-30	13F	ROCKET PHARMACEUTICALS	COM	77313F106	102,538	-72,372	-41.38	334	-21.96	0.0003
2025-07-28	2025-06-30	13F	ROCKET PHARMACEUTICALS	COM	77313F106	174,910	12,200	7.50	429	-60.55	0.0004
2025-05-07	2025-03-31	13F	ROCKET PHARMACEUTICALS	COM	77313F106	162,710	-15,744	-8.82	1,085	-51.63	0.0010
2025-02-11	2024-12-31	13F	ROCKET PHARMACEUTICALS	COM	77313F106	178,454	844	0.48	2,243	-31.57	0.0020
2024-11-01	2024-09-30	13F	ROCKET PHARMACEUTICALS	COM	77313F106	177,610	-554	-0.31	3,279	-14.52	0.0029
2024-08-02	2024-06-30	13F	ROCKET PHARMACEUTICALS	COM	77313F106	178,164	23,000	14.82	3,836	-8.25	0.0036
2024-05-08	2024-03-31	13F	ROCKET PHARMACEUTICALS	COM	77313F106	155,164	300	0.19	4,180	-9.93	0.0039
2024-02-12	2023-12-31	13F	ROCKET PHARMACEUTICALS	COM	77313F106	154,864	42,834	38.23	4,641	102.22	0.0046
2023-10-27	2023-09-30	13F	ROCKET PHARMACEUTICALS	COM	77313F106	112,030	56,015	100.00	2,295	106.20	0.0028
2023-08-09	2023-06-30	13F	ROCKET PHARMACEUTICALS	COM	77313F106	56,015	16,100	40.34	1,113	62.96	0.0013
2023-05-10	2023-03-31	13F	ROCKET PHARMACEUTICALS	COM	77313F106	39,915	-2,300	-5.45	684	-17.31	0.0008
2023-02-07	2022-12-31	13F	ROCKET PHARMACEUTICALS	COM	77313F106	42,215	9,063	27.34	826	77.63	0.0010
2022-11-07	2022-09-30	13F	ROCKET PHARMACEUTICALS	COM	77313F106	33,152	-33,031	-49.91	465	-48.96	0.0006
2022-08-04	2022-06-30	13F	ROCKET PHARMACEUTICALS	COM	77313F106	66,183	0	0.00	911	-13.24	0.0011
2022-05-10	2022-03-31	13F	ROCKET PHARMACEUTICALS	COM	77313F106	66,183	0	0.00	1,050	-27.34	0.0006
2022-02-10	2021-12-31	13F	ROCKET PHARMACEUTICALS	COM	77313F106	66,183	-16,700	-20.15	1,445	-41.66	0.0012
2021-11-09	2021-09-30	13F	ROCKET PHARMACEUTICALS	COM	77313F106	82,883	0	0.00	2,477	-16.57	0.0026
2021-08-11	2021-06-30	13F	ROCKET PHARMACEUTICALS	COM	77313F106	82,883	-6,050	-6.80	2,969	-24.76	0.0030
2021-05-14	2021-03-31	13F	ROCKET PHARMACEUTICALS	COM	77313F106	88,933	9,509	11.97	3,946	-9.41	0.0044
2021-02-16	2020-12-31	13F	ROCKET PHARMACEUTICALS	COM	77313F106	79,424	17,361	27.97	4,356	206.98	0.0053
2020-11-10	2020-09-30	13F	ROCKET PHARMACEUTICALS	COM	77313F106	62,063	22,858	58.30	1,419	72.84	0.0020
2020-08-13	2020-06-30	13F	ROCKET PHARMACEUTICALS	COM	77313F106	39,205	0	0.00	821	50.09	0.0012
2020-05-15	2020-03-31	13F	ROCKET PHARMACEUTICALS	COM	77313F106	39,205	-9,300	-19.17	547	-50.45	0.0009
2020-02-11	2019-12-31	13F	ROCKET PHARMACEUTICALS	COM	77313F106	48,505	11,173	29.93	1,104	153.79	0.0016
2019-11-07	2019-09-30	13F	ROCKET PHARMACEUTICALS	COM	77313F106	37,332	8,189	28.10	435	-0.46	0.0007
2019-08-01	2019-06-30	13F	ROCKET PHARMACEUTICALS	COM	77313F106	29,143	5,180	21.62	437	4.05	0.0007
2019-05-08	2019-03-31	13F	ROCKET PHARMACEUTICALS	COM	77313F106	23,963	-1,300	-5.15	420	12.30	0.0006
2019-02-01	2018-12-31	13F	ROCKET PHARMACEUTICALS	COM	77313F106	25,263	4,768	23.26	374	-25.94	0.0007
2018-11-01	2018-09-30	13F	ROCKET PHARMACEUTICALS	COM	77313F106	20,495	0	0.00	505	25.62	0.0007
2018-07-31	2018-06-30	13F	ROCKET PHARMACEUTICALS	COM	77313F106	20,495	300	1.49	402	6.07	0.0006
2018-05-11	2018-03-31	13F	ROCKET PHARMACEUTICALS	COM	77313F106	20,195	-21,005	-50.98	379	51.00	0.0006
2017-02-08	2016-12-31	13F	INOTEK PHARMACEUTICALS	COM	45780V102	41,200	-500	-1.20	251	-36.46	0.0004
2016-11-02	2016-09-30	13F	INOTEK PHARMACEUTICALS	COM	45780V102	41,700	9,900	31.13	395	66.67	0.0007
2016-08-04	2016-06-30	13F	INOTEK PHARMACEUTICALS	COM	45780V102	31,800	-400	-1.24	237	-0.42	0.0004
2016-05-05	2016-03-31	13F	INOTEK PHARMACEUTICALS	COM	45780V102	32,200	-1,000	-3.01	238	-36.70	0.0004
2016-02-04	2015-12-31	13F	INOTEK PHARMACEUTICALS	COM	45780V102	33,200	-8,500	-20.38	376	-4.08	0.0007
2015-11-12	2015-09-30	13F	INOTEK PHARMACEUTICALS	COM	45780V102	41,700	41,700		392		0.0008

Legend

Shares: The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value: The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price: The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class: This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred

Allocation (%): The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation: The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%): The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis: The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss: This is the market value of the position as of the effective date minus the cost basis.